Interleukin-6 in Covid-19: A systematic review and meta-analysis
코로나19의 인터루킨-6: 체계적인 검토 및 메타 분석
Meta-Analysis
[키워드] 95% confidence interval
95%CI
activate
authors
clinical outcomes
Concentration
COVID-19
cytokine
Cytokine storm
demonstrated
disease
dysregulated
elevated
eligible
Evidence
exploratory study
for inclusion
Grey literature
host immune responses
host response
ICU admission
IL-6
IL-6 level
IL-6 levels
IL6
immune responses
Immunological response
inhibition
interleukin
interleukin-6
Intervention
management
Meta-analysis
moderate
Patient
random effect
required
Risk of bias
SARS-CoV-2
searched
Sensitivity analyses
sensitivity analysis
significantly
suggested
systematic review
Therapeutics
Tocilizumab
were assessed
[DOI] 10.1002/rmv.2141 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1002/rmv.2141 PMC 바로가기 [Article Type] Meta-Analysis